Wave Life Sciences to Present at Jefferies Virtual Healthcare Conference
May 28 2021 - 8:30AM
Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage
genetic medicines company committed to delivering life-changing
treatments for people battling devastating diseases, announced
today that Paul Bolno, MD, MBA, President and Chief Executive
Officer, is scheduled to give a presentation at the Jefferies
Virtual Healthcare Conference on Wednesday, June 2,
2021 at 11:30 a.m. ET. Dr. Bolno will provide a corporate
update and discuss Wave’s pipeline programs, including the first in
vivo data from the company’s ADAR editing discovery program for
alpha-1 antitrypsin deficiency (AATD).
A live webcast of the presentation will be available on the
investor relations page of the Wave Life
Sciences corporate website
at http://ir.wavelifesciences.com. A replay of the
presentation will be archived and available at that site for 90
days following the event.
About Wave Life Sciences Wave Life
Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines
company committed to delivering life-changing treatments for people
battling devastating diseases. Wave aspires to develop
best-in-class medicines across multiple therapeutic modalities
using PRISM, the company’s proprietary discovery and drug
development platform that enables the precise design, optimization
and production of stereopure oligonucleotides. Driven by a resolute
sense of urgency, the Wave team is targeting a broad range of
genetically defined diseases so that patients and families may
realize a brighter future. To find out more, please
visit www.wavelifesciences.com and follow Wave on Twitter
@WaveLifeSci.
Investor Contact:Kate
Rausch617-949-4827krausch@wavelifesci.com
Media Contact:Alicia
Suter617-949-4817asuter@wavelifesci.com
Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From Apr 2023 to Apr 2024